NeuroOne Medical Technologies Corporation announced the appointment of Jason Mills to its Board of Directors on December 18, 2025.
Jason Mills has an extensive background in med-tech as a Corporate Executive and Industry Investment Analyst.
His appointment brings strategic experience, industry relationships, and vision to the Board.
Jason Mills' Background
Jason Mills is a veteran Med-Tech Research Analyst with over two decades of experience in the industry.
Impact on NeuroOne
Jason Mills' expertise is expected to enhance NeuroOne's progress in clinical and corporate goals.
Strategic Value
The appointment aims to expand the company's reach in transforming the diagnosis and treatment of neurological disorders.
- Jason Mills' appointment signifies NeuroOne's commitment to strengthening its Board with industry expertise and strategic vision.
- His contribution is expected to drive value for shareholders and advance the company's goals in the med-tech sector.
With Jason Mills joining the Board, NeuroOne is well-positioned to leverage his expertise and insights to further innovate in the medical technology sector.